Theravance Biopharma (TBPH) EBT Margin Growth (5y) (2018 - 2026)
Theravance Biopharma (TBPH) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38,439.00 |
| Mar 31, 2026 | 52,073.00 |
| Dec 31, 2025 | 56,246.00 |
| Sep 30, 2025 | 38,841.00 |
| Jun 30, 2025 | 69,823.00 |
| Mar 31, 2025 | 32,553.00 |
| Dec 31, 2024 | -2,035.00 |
| Sep 30, 2024 | 45,528.00 |
| Jun 30, 2024 | -3,337.00 |
| Mar 31, 2024 | 128,646.00 |
| Dec 31, 2023 | 31,104.00 |
| Sep 30, 2023 | 41,976.00 |
| Jun 30, 2023 | 9,961.00 |
| Mar 31, 2023 | 56,483.00 |
| Dec 31, 2022 | 167,305.00 |
| Sep 30, 2022 | 141,538.00 |
| Jun 30, 2022 | 166,980.00 |
| Mar 31, 2022 | 164,045.00 |
| Dec 31, 2021 | 64,458.00 |
| Sep 30, 2021 | -25,002.00 |